Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma

Brian W. Loggie, R. A. Fleming, A. A. Hosseinian

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.

Original languageEnglish
Pages (from-to)446-448
Number of pages3
JournalUrology
Volume50
Issue number3
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Adenocarcinoma
Carcinoma
Drug Therapy
Peritoneal Diseases
Neoplasm Metastasis
Bone and Bones
Recurrence
Urachal adenocarcinoma
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. / Loggie, Brian W.; Fleming, R. A.; Hosseinian, A. A.

In: Urology, Vol. 50, No. 3, 09.1997, p. 446-448.

Research output: Contribution to journalArticle

Loggie, Brian W. ; Fleming, R. A. ; Hosseinian, A. A. / Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. In: Urology. 1997 ; Vol. 50, No. 3. pp. 446-448.
@article{419767bd25384890afebd61e6476069a,
title = "Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma",
abstract = "Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.",
author = "Loggie, {Brian W.} and Fleming, {R. A.} and Hosseinian, {A. A.}",
year = "1997",
month = "9",
doi = "10.1016/S0090-4295(97)00247-1",
language = "English",
volume = "50",
pages = "446--448",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma

AU - Loggie, Brian W.

AU - Fleming, R. A.

AU - Hosseinian, A. A.

PY - 1997/9

Y1 - 1997/9

N2 - Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.

AB - Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.

UR - http://www.scopus.com/inward/record.url?scp=0030858169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030858169&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(97)00247-1

DO - 10.1016/S0090-4295(97)00247-1

M3 - Article

VL - 50

SP - 446

EP - 448

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -